Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Alabama Neurology Associates, PC.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Biogen Idec
Information provided by:
Alabama Neurology Associates, PC
ClinicalTrials.gov Identifier:
NCT00242268
First received: October 19, 2005
Last updated: December 6, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given